However, it has been demonstrated that several GPCR‐based drugs, such as dopamine and blockers, have significant effects on cardiac and psychological functions; as a result, adverse effects must be addressed before using these drugs in cancer treatment [243, 244] (Figure 5A). This evidence concerns the gene FZD4 and cancer.